We are pleased to announce that by the second half of 2024, El Salvador will have Suplasyn 1-SHOT®, a hyaluronic acid for viscosupplementation in the symptomatic treatment of osteoarthritis.

SUPLASYN® has been shown to be beneficial in osteoarthritis to treat pain and improve the physical function of the joints, allowing more than one joint to be treated at the same time. It is suitable for large joints, designed to provide the patient and the doctor with greater ease as it is a single administration, with an excellent safety profile due to its biotechnological origin.